tiprankstipranks
Taysha Gene Therapies, Inc. (TSHA)
NASDAQ:TSHA
US Market
TSHA
Taysha Gene Therapies
RESEARCH TOOLSreports
Want to see TSHA full AI Analyst Report?

Taysha Gene Therapies (TSHA) Financial Statements

1,255 Followers

Taysha Gene Therapies Financial Overview

Taysha Gene Therapies's market cap is currently $1.84B. The company's EPS TTM is $-0.08; its P/E ratio is -16.13; Taysha Gene Therapies is scheduled to report earnings on March 19, 2026, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Mar 22
Income Statement
Total Revenue$ 9.77M$ 8.33M$ 15.45M$ 2.50M$ 0.00
Gross Profit$ 8.63M$ 8.33M$ 15.45M$ 15.00K$ 0.00
Operating Income$ -110.50M$ -91.46M$ -72.44M$ -126.03M$ -173.27M
EBITDA$ -109.35M$ -87.95M$ -105.20M$ -159.73M$ -172.60M
Net Income$ -109.00M$ -89.30M$ -111.57M$ -166.01M$ -174.52M
Balance Sheet
Cash & Short-Term Investments$ 319.77M$ 139.04M$ 143.94M$ 87.88M$ 149.10M
Total Assets$ 343.32M$ 160.36M$ 172.73M$ 126.28M$ 213.96M
Total Debt$ 18.17M$ 63.18M$ 61.11M$ 59.93M$ 63.09M
Net Debt$ -301.60M$ -75.86M$ -82.83M$ -27.95M$ -86.01M
Total Liabilities$ 96.38M$ 88.84M$ 97.79M$ 125.33M$ 118.57M
Stockholders' Equity$ 246.94M$ 71.53M$ 74.94M$ 949.00K$ 95.38M
Cash Flow
Free Cash Flow$ -93.83M$ -81.60M$ -80.39M$ -113.26M$ -138.60M
Operating Cash Flow$ -93.09M$ -81.22M$ -73.02M$ -88.39M$ -117.04M
Investing Cash Flow$ -604.00K$ -363.00K$ -7.35M$ -24.93M$ -21.55M
Financing Cash Flow$ 274.59M$ 76.68M$ 136.39M$ 52.10M$ 39.08M
Currency in USD

Taysha Gene Therapies Earnings and Revenue History

Income Statement >

Taysha Gene Therapies Debt to Assets

Balance Sheet >

Taysha Gene Therapies Cash Flow

Cash Flow >

Taysha Gene Therapies Forecast EPS vs Actual EPS

Earnings >